Navigation Links
Cepheid Reports Second Quarter Revenue of $42.1 Million
Date:7/24/2008

g the Company's cash requirements and additional insight into the underlying operating results and the Company's ongoing performance in the ordinary course of its operations.

These non-GAAP measures may be different from non-GAAP measures used by other companies. In addition, these non-GAAP measures are not based on any comprehensive set of accounting rules or principles. The Company believes that non-GAAP measures have limitations in that they do not reflect all of the amounts associated with its results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate the Company's results of operations in conjunction with the corresponding GAAP measures.

As described above, the Company excludes the following items from one or more of its non-GAAP measures when applicable:

Employee share-based compensation expense. These expenses consist primarily of expenses for employee stock options and employee restricted stock under SFAS 123(R). The Company excludes employee share-based compensation expenses from its non-GAAP measures primarily because they are non-cash expenses that the Company does not believe are reflective of ongoing operating results. Further, as the Company applies SFAS 123(R), it believes that it is useful to investors to understand the impact of the application of SFAS 123(R) to its results of operations.

Amortization of purchased intangible assets. The Company incurs amortization of purchased intangible assets in connection with acquisitions and investments. The Company excludes these items because these expenses are not reflective of ongoing operating results in the period incurred. These amounts arise from the Company's prior acquisitions and have no direct correlation to the operation of the Company's business.

Forward Looking Statements

This press release contains forward-looking statements that are not purely historical regarding Cepheid's or its management's int
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
3. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
4. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
5. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
6. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
7. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
8. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
9. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
10. Cepheid Reports Fourth Quarter and Full Year 2007 Results
11. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 2 Nearly 600 medical r... funders today convened to explore novel developme... the inaugural Partnering for Cures meeting. ,...the Milken Institute, convened Partnering for Cur...ed to turn a scientific discovery into an accessib...
(Date:12/2/2009)..., Gabon, December 2 , - "...lem and Heritage" , Coinciding with the I...he,Gabonese Republic is hosting an international c...feguarding biological resources in Africa. The,con...eaders, ministers,scientific experts, private com...
(Date:12/2/2009)..., Dec. 2 S*BIO Pte Ltd today annou...ibitor, SB1518, at The American Society of Hematol...ans. ,, Data will be presented on the clinical ...SB1518 detailing its safety, tolerability and phar...e levels ranging from 100 to 600 mg. These doses w...
(Date:12/2/2009)..., Dec. 2 /PRNewswire-Asia/ -- The world is going t... and uncertainty is part of many,businesses and in...s been,relatively immune to the economic downturn,... During the midst of the difficult times this ye... inaugurated an R&D center in Shanghai, the la...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
...e quantities of difficult-to-express proteins ,...iochemical & Molecular Allergology, Research Cente...odonPlus(DE3)-RIL cells * with,extra copies of E...ossible to attain high-level expression of difficu...nduced expression of several recombinant peanut al...
...RoboCycler Gradient 96 temperature cycler ,,.... , Stratagenes RoboCycler Gradient 96 tempera...ed to perform fluorescent-tag cycle,sequencing u...ing,ready reaction kit. The new Hot Top Assembly...ays that hinder the loading of cycle sequencing re...
...,, Achieve superior transfection efficiencie...cott Basehore Jeff Braman ,Stratagene , Plasm...,EF plasmid midiprep kit, a kit based on anion e...um chloride density gradient centrifugation. Plasm...-nm optical density ratios) were comparable,with...
Other Biology Technology:High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 2High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 3High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 4Automated Fluorescent-Tag Cycle Sequencing 2Automated Fluorescent-Tag Cycle Sequencing 3Automated Fluorescent-Tag Cycle Sequencing 4Automated Fluorescent-Tag Cycle Sequencing 5Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell,Line 2Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell,Line 3Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell,Line 4
(Date:12/3/2009)...design of the upcoming forest deal at Copenhagen i...to a scientist at the University of Leeds. , Wr...t at least 50% of the carbon credit payments to be...ssions from Deforestation and Degredation), should...operty rights assured. , "There is the potential...
(Date:12/3/2009)... U.S. Department of Energy,s (DOE) Brookhaven Nati...n Institute of Science has made a major step in un...mation in DNA that is necessary to carry out impor... in the December 1, 2009 edition of Nature Struct...eins responsible for interacting at specific sites...
(Date:12/2/2009)...no men have a more difficult time quitting smoking...ure, but acculturation has no affect on Latinas od...are published in Cancer Epidemiology, Biomarkers ...on for Cancer Research. The December issue has a s...s smoking cessation differently for Latino men and...
Breaking Biology News(10 mins):Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Grooving down the helix 2Grooving down the helix 3Acculturation affects smoking cessation success among Latinos 2A Pets Bite Can Pass on MRSA 49599 1A Pets Bite Can Pass on MRSA 49599 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 1Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 3Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 4HealthLeaders InterStudy Unveils Enhanced Employer Vantage 49589 1HealthLeaders InterStudy Unveils Enhanced Employer Vantage 49589 2
... desperately try to reach for a break in the canop... affliction: Shade avoidance syndrome or SAS. Now,... light by researchers at the Salk Institute for Bi...rs shade, plants switch on a natural chemical fact...auxin that lets a plant grow and ultimately stretc...
...the inaugural conference of the iPlant Collaborati... virtual center in cyberspace for plant sciences r...itled "Bringing Plant and Computing Scientists Tog...nd scheduled for April 7-9, 2008, will take the fi...test unsolved mysteries its grand challenge quest...
... Society of Agronomy (ASA), Crop Science Society o...ica (SSSA) recognize the following undergraduate s... National Student Recognition Program announced in...ine. , The 2008 National Student Recognition Prog...s enrolled in agronomy, crop, soil, or environment...
Other Biology News:A place in the sun 2A place in the sun 3iPlant Kickoff Conference at CSHL begins tackling plant biology's grand challenges 2iPlant Kickoff Conference at CSHL begins tackling plant biology's grand challenges 3Outstanding undergraduates recognized in agronomy, crop, soil, and environmental sciences 2
...noCortin (POMC) has long been a molecule of fascin... of biologically-active peptides such as ACTH, -Li...mulating Hormone (a-MSH) and more. It is also a ve...rtebrates studied, including those "living fossils...
Mouse Anti-Rat Pan-NMDA NR1 Monoclonal Antibody, Unconjugated, Clone R1JHL from Calbiochem
BRASMC (B950-05) from European Collection of Cell Cultures (ECACC)
T4 DNA Ligase from Promega
Biology Products: